0001104659-19-038307.txt : 20190628
0001104659-19-038307.hdr.sgml : 20190628
20190628171555
ACCESSION NUMBER: 0001104659-19-038307
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190625
FILED AS OF DATE: 20190628
DATE AS OF CHANGE: 20190628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cline Darren S
CENTRAL INDEX KEY: 0001633639
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35619
FILM NUMBER: 19930428
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: STEMLINE THERAPEUTICS INC
CENTRAL INDEX KEY: 0001264587
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450522567
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
STREET 2: ELEVENTH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 646-502-2311
MAIL ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
a4.xml
4
X0306
4
2019-06-25
0
0001264587
STEMLINE THERAPEUTICS INC
STML
0001633639
Cline Darren S
C/O STEMLINE THERAPEUTICS, INC.
750 LEXINGTON AVENUE, ELEVENTH FLOOR
NEW YORK
NY
10022
1
0
0
0
Common Stock
2019-06-25
4
A
0
15000
0
A
35468
D
The restricted shares will vest according to the following schedule: 5,000 shares on 6/25/2020, 5,000 shares on 6/25/2021 and 5,000 shares on 6/25/2022.
Of the 35,468 shares, 28,645 shares are restricted stock.
/s/ Kenneth Hoberman, Attorney-in-Fact
2019-06-28